Total Payments
$4,349
2024 Payments
$546.33
Companies
22
Transactions
153
Medicare Patients
7,116
Medicare Billing
$332,354
Payment Breakdown by Category
Food & Beverage$3,569 (82.1%)
Travel$779.46 (17.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,569 | 150 | 82.1% |
| Travel and Lodging | $779.46 | 3 | 17.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $1,169 | 40 | $0 (2024) |
| Hill-Rom Company, Inc | $916.61 | 4 | $0 (2019) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $394.62 | 31 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $379.27 | 11 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $274.98 | 16 | $0 (2024) |
| ABIOMED | $258.34 | 3 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $200.76 | 12 | $0 (2024) |
| Endologix, Inc. | $185.96 | 2 | $0 (2018) |
| PFIZER INC. | $129.12 | 8 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $75.44 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $546.33 | 29 | Abbott Laboratories ($201.87) |
| 2023 | $449.56 | 28 | Abbott Laboratories ($287.17) |
| 2022 | $204.08 | 10 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($61.16) |
| 2021 | $374.61 | 16 | ABIOMED ($185.24) |
| 2020 | $184.83 | 4 | Abbott Laboratories ($158.29) |
| 2019 | $1,285 | 18 | Hill-Rom Company, Inc ($916.61) |
| 2018 | $540.24 | 25 | Abbott Laboratories ($182.66) |
| 2017 | $764.42 | 23 | AstraZeneca Pharmaceuticals LP ($294.16) |
All Payment Transactions
153 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Abbott Laboratories | XIENCE SKYPOINT (Device) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: Vascular | ||||||
| 12/10/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $12.32 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/25/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $23.57 | General |
| Category: Cardiovascular | ||||||
| 11/07/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/30/2024 | Abbott Laboratories | XIENCE SKYPOINT (Device) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: Vascular | ||||||
| 09/24/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/29/2024 | Abbott Laboratories | XIENCE SKYPOINT (Device) | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: Vascular | ||||||
| 07/18/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/16/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/03/2024 | Abbott Laboratories | XIENCE SKYPOINT (Device) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Vascular | ||||||
| 06/06/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.75 | General |
| Category: Cardiovascular | ||||||
| 06/05/2024 | Abbott Laboratories | AMPLATZER AMULET (Device) | Food and Beverage | In-kind items and services | $27.56 | General |
| Category: Structural Heart | ||||||
| 05/24/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/23/2024 | Abbott Laboratories | XIENCE SKYPOINT (Device) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: Vascular | ||||||
| 05/16/2024 | Abbott Laboratories | XIENCE SKYPOINT (Device) | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: Vascular | ||||||
| 05/07/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/03/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/26/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Cardio-renal | ||||||
| 03/13/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/05/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: Cardiology | ||||||
| 02/17/2024 | Boston Scientific Corporation | ROTAPRO (Device) | Food and Beverage | In-kind items and services | $30.09 | General |
| Category: ROTAPRO_IC | ||||||
| 02/09/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $23.19 | General |
| Category: Cardiovascular | ||||||
| 02/06/2024 | Abbott Laboratories | XIENCE SKYPOINT (Device) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: Vascular | ||||||
| 01/25/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/19/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $20.77 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 3,870 | 5,548 | $547,136 | $176,873 |
| 2022 | 21 | 2,289 | 2,592 | $286,140 | $98,848 |
| 2021 | 9 | 583 | 721 | $102,712 | $38,005 |
| 2020 | 5 | 374 | 422 | $59,889 | $18,627 |
Total Patients
7,116
Total Services
9,283
Medicare Billing
$332,354
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 538 | 702 | $124,653 | $39,110 | 31.4% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 1,124 | 1,717 | $83,527 | $26,064 | 31.2% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 737 | 1,015 | $68,595 | $21,658 | 31.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 174 | 206 | $56,514 | $18,039 | 31.9% |
| 93284 | Programming of multiple lead implantable defibrillator system | Office | 2023 | 122 | 152 | $36,110 | $11,239 | 31.1% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 279 | 379 | $31,610 | $10,057 | 31.8% |
| 93283 | Programming of dual lead implantable defibrillator system | Office | 2023 | 109 | 145 | $31,959 | $9,909 | 31.0% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 91 | 294 | $11,118 | $8,216 | 73.9% |
| 93279 | Programming of single lead pacemaker system | Office | 2023 | 114 | 151 | $22,541 | $7,052 | 31.3% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 88 | 205 | $12,114 | $3,952 | 32.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 40 | 41 | $11,907 | $3,692 | 31.0% |
| 93282 | Programming of single lead implantable defibrillator system | Office | 2023 | 48 | 60 | $10,920 | $3,347 | 30.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $9,328 | $2,951 | 31.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 21 | 22 | $9,130 | $2,566 | 28.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 192 | 235 | $7,050 | $2,333 | 33.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 25 | 38 | $6,224 | $2,081 | 33.4% |
| 93281 | Programming of multiple lead pacemaker system | Office | 2023 | 13 | 18 | $3,402 | $1,104 | 32.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 12 | $3,016 | $1,029 | 34.1% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Office | 2023 | 17 | 18 | $2,264 | $668.80 | 29.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 11 | 17 | $1,450 | $585.60 | 40.4% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 32 | 34 | $1,094 | $446.08 | 40.8% |
| 93291 | Evaluation of cardiac rhythm monitor system | Office | 2023 | 11 | 12 | $1,326 | $395.50 | 29.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 36 | 38 | $699.00 | $198.23 | 28.4% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 11 | 11 | $585.00 | $178.69 | 30.5% |
| 93280 | Programming of dual lead pacemaker system | Office | 2022 | 315 | 348 | $58,180 | $20,524 | 35.3% |
About Dr. Herbert Ladley, MD
Dr. Herbert Ladley, MD is a Interventional Cardiology healthcare provider based in Kingsport, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174552467.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Herbert Ladley, MD has received a total of $4,349 in payments from pharmaceutical and medical device companies, with $546.33 received in 2024. These payments were reported across 153 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($3,569).
As a Medicare-enrolled provider, Ladley has provided services to 7,116 Medicare beneficiaries, totaling 9,283 services with total Medicare billing of $332,354. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Other Specialties Cardiovascular Disease
- Location Kingsport, TN
- Active Since 07/01/2006
- Last Updated 05/24/2017
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1174552467
Products in Payments
- Hill-Rom Heart and Respiration Rate Monitoring System powered by EarlySense (Device) $916.61
- LifeVest (Device) $394.62
- XIENCE SKYPOINT (Device) $383.07
- Supera peripheral stent system (Device) $278.53
- ENTRESTO (Drug) $258.41
- Impella (Device) $258.34
- BRILINTA (Drug) $184.61
- ELIQUIS (Drug) $175.64
- CAMZYOS (Drug) $113.05
- Xience V coronary stent system (Device) $104.69
- Xience Sierra Coronary Stent System (Device) $99.80
- Mitra Clip system (Device) $88.18
- XIENCE SIERRA (Device) $78.41
- XARELTO (Drug) $75.44
- CardioMEMS HF System (Device) $60.18
- JARDIANCE (Drug) $52.73
- XACT (Device) $48.87
- AVALUS (Device) $36.55
- ROTAPRO (Device) $30.09
- Repatha (Biological) $28.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.